Predicting the Presence of Nonmelanoma Skin Cancers After Biopsy | Zendy

Sarah E. Sasor | Zendy; Naveed Nosrati | Zendy; Terrence M. Katona | Zendy; William A. Wooden | Zendy; Adam C. Cohen | Zendy; Imtiaz A. Munshi | Zendy; Sunil S. Tholpady | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predicting the Presence of Nonmelanoma Skin Cancers After Biopsy

Author(s) -

Sarah E. Sasor,

Naveed Nosrati,

Terrence M. Katona,

William A. Wooden,

Adam C. Cohen,

Imtiaz A. Munshi,

Sunil S. Tholpady

Publication year - 2015

Publication title -

jama surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.757

H-Index - 176

eISSN - 2168-6262

pISSN - 2168-6254

DOI - 10.1001/jamasurg.2015.3243

Subject(s) - medicine , skin cancer , dermatology , biopsy , skin biopsy , punch biopsy , pathology , cancer

ASSOCIATION OF VA SURGEONS Predicting the Presence of Nonmelanoma Skin Cancers After Biopsy: A Method to Reduce Unnecessary Surgical Procedures Nonmelanoma skin cancer (NMSC) is the most common type of skin cancer in the United States.1 The incidence of NMSC has nearly doubled in the past 20 years, creating a significant financial burden on health care systems.1 The current recommended surgical treatment of NMSC is complete reexcision of the biopsy scar with a several-millimeter margin. Studies2-4 have shown spontaneous clearance rates of 24% to 72% after biopsy and have tried to identify associated characteristics. Previous data from our institution suggest that the clinical appearance of a scar was associated with no cancer after surgical excision.5 The purpose of this study was to determine whether clearance of NMSC in excisional specimens can be predicted based on the appearance of a lesion after biopsy and on the demographic characteristics of the patient.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research